Speaker Information
Meet the speaker and learn more about their expertise, experience, and contribution to advancing innovation in paediatric medicines and clinical research.
Covadonga Terol Espinosa de los Monteros
National Expert (Secondment),
Paediatric Medicines Office, European Medicines Agency
Dr. Covadonga Terol Espinosa de los Monteros, MD, PhD, is a physician–scientist and paediatric cardiologist with expertise in clinical research and regulatory science in paediatric cardiovascular diseases. She is currently serving as a National Expert on Secondment within the Paediatric Medicines Office at the European Medicines Agency, where she contributes to the assessment of Paediatric Investigation Plans (PIPs) and regulatory decision-making for paediatric medicines across the European Union, with involvement in cardiovascular products, including therapies for pulmonary arterial hypertension (PAH) and heart failure.
Before joining the EMA, Dr. Terol worked as a paediatrician and paediatric cardiologist in several public hospitals in Madrid, combining clinical work in paediatric cardiology, general paediatrics, and neonatology.
Then she completed her PhD at Leiden University, conducted at the Leiden University Medical Center, entitled Advanced Non-Invasive Diagnostics in Congenital Heart Disease. Her research focused on advanced echocardiographic techniques and alternative cardiopulmonary exercise testing parameters to improve long-term risk stratification and clinical decision-making in paediatric patients with congenital heart disease. Her work also incorporated impedance cardiography and innovative unsupervised clustering approaches for cardiovascular risk stratification. During her PhD, she was part of the paediatric echocardiography team at the Leiden University Medical Center, performing and interpreting echocardiographic studies in children with congenital and acquired heart disease. She has authored multiple peer-reviewed publications in paediatric cardiology and congenital heart disease.